Compliance, tolerance and efficacy of a short course of chemoprophylaxis for tuberculosis;Cumplimentacion, tolerancia y eficacia de una pauta corta de quimioprofilaxis para el tratamiento de la tuberculosis

Medicina Clinica

Volumn 111, Issue 11, 1998, Pages 401-404

  Alfaro, Elisa Martínez ^a   Solera, Javier ^a   Serna, Emilio ^a   Cuenca, Dolores ^a   Castillejos, María Luisa ^a   Espinosa, Alfredo ^a   Sáez, Lourdes ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; ISONIAZID PLUS RIFAMPICIN; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ADVERSE DRUG REACTION; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TUBERCULOSIS; COMPARATIVE STUDY; DRUG COMBINATION; MIDDLE AGED; PROSPECTIVE STUDY; TIME;

ADULT; ANTITUBERCULAR AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; ISONIAZID; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; RIFAMPIN; TIME FACTORS; TUBERCULOSIS;

EID: 0032505334     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Casal M. La tuberculosis como problema sanitario a las puertas del 2000. Enfsrm Infecc Microbiol Clin 1993; 11: 291-293.
2. De March Ayuela P. Situación actual de la tuberculosis en España. Med Clin (Barc) 1991; 97; 463-472.
3. CDC. Screening for tuberculosis and tuberculosis infection in high-risk populations. Recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR 1990; 39 (Supl RR-8): 1-7.
4. a ed.). Buenos Aires: Editorial Médica Panamericana 1991; 1.986-2.017.
5. Vidal R, Miravitlles M, Caylà JA, Torrella M, Martin N, De Garcia J. Estudio de contactas familiares de enfermes con tuberculosis. Med Clin (Barc) 1997; 108: 361-365.
6. Caminero Luna JA. Medidas basics para el control de la tuberculosis en una comunidad. Med Clin (Barc) 1994; 102: 67-73.
7. Grupo de Trabajo sobre Tuberculosis. Consenso nacional para el control de la tuberculosis en Espana. Med Clin (Barc) 1992; 98: 24-31.
8. CDC. The use of preventive therapy for tuberculosis infection in the United States. Recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR 1990; 39 (Supl RR-8): 9-12.
9. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Adv Tuberc Res 1970; 17: 28-106.
10. De March Ayuela P. ¿Puede acortarse la quimioprofilaxis corta de la tuberculosis. Arch Bronconeumol 1991; 25: 210-213.
11. International Union against Tuberculosis. Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis; five years of follow-up in the IUALT trial. Bull WHO 1982; 60: 555-564.
12. McNicol MW, Thompson H, Riordan JF, Forde E, Allen CJ. Antituberculous chemoprophylaxis with isoniazid-rifampin. Thorax 1984; 39: 223-224.
13. Girling DJ. Double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Am Rev Respir Dis 1992; 145: 36-41.
14. Kapetaneas S, Rapti A, Chrisiotis C, Anagnostopulo U. Short-term chemoprophylaxis. Experience in Greece. Am Rev Respir Dis 1990; 141: A437.
15. Felten M, Merwe CA, Random variation in tuberculin sensitivity in schoolchildren. Serial skin testing before and after preventive treatment of tuberculosis. Am Rev Respir Dis 1989 140: 1.001-1.006.
16. Lecoeur HF, Truffot-Pernot C, Grosset JH. Experimental short-course preventive therapy of tuberculosis with rifampin and pirazinamide. Am Rev Respir Dis 1989; 140: 1.189-1.193.
17. British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations of the Joint Tuberculosis Committee of the British Thoracic Society. Thorax 1990; 45: 403-408.
18. March Ayuela P, Espinar Marti A, Gaton Roson A, Pina Gutiérrez JM, Rey Durán R, Mdal Pla R. Quimioprofilaxis antituberculosa. Recomendaciones SEPAR. Arch Bronconeumol 1992; 28: 270-278.
19. Dean AG, Dean JA, Coulombier D. Epi Info, version 6: a word processing, database and statistics program for epidemiology of microcomputers. Atlanta: Centers for Disease Control and Prevention, 1994.
20. Yuan L, Richardson E, Kendall PRW. Evaluation of a tuberculosis screening program for high-risk student in Toronto schools. Can Med Assoc J 1995; 153: 925-932.
21. Gavira R, Gómez F, Otero MJ, Barrueco M, Dominguez-Gil A. Seguimiento del tratamiento antituberculoso. Rev Clin Esp 1994; 194: 677-685.
22. Malcolm AS, Burk RF, Des Prez RM, Toxic hepatitis with isoniacid and rifampin. A meta-analysis. Chest 1991; 99: 465-471.
23. Vidai Pla R, De Garcia X, Gallego B, Aigueró C, Bravo C. Hepatotoxicidad del tratamiento de la tuberculosis. Med Clin (Barc) 1991; 97: 481-485.